Your session is about to expire
← Back to Search
Inactivated Influenza Vaccine for Influenza (FLU-LN Trial)
FLU-LN Trial Summary
This trial is testing how well the flu vaccine works in people with HIV.
- Influenza
FLU-LN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFLU-LN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FLU-LN Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your body weight is within a healthy range based on your height.You are allergic to eggs or any ingredients in the vaccine.You have a weakened immune system, including a history of HIV infection.You have a condition that weakens your immune system, such as severe liver disease, diabetes treated with insulin, or significant kidney disease.You had a severe, life-threatening reaction to a previous flu vaccine.You have had Guillain-Barre syndrome in the past.You have used or are planning to use experimental medications within the past month.
- Group 1: Study Phase
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has this particular therapy received governmental authorization?
"The safety of this therapeutic intervention is rated a 3 on our 1-3 scale due to it being in its fourth phase, which indicates that the treatment has already been approved."
What is the sample size of this research project?
"Affirmative, the clinicaltrials.gov portal indicates that recruitment for this medical trial is ongoing. It was first listed on April 11th 2019 and modified most recently on May 3rd 2022. The investigation aims to include 50 individuals from a single research centre."
Is the enrollment process for this experiment currently open?
"Yes, according to clinicaltrials.gov, this biomedical research is currently enrolling 50 individuals from one centre; the trial was originally posted on April 11th 2019 and recently updated on May 3rd 2022."
What are the requirements for participating in this trial?
"Eligibility for the experiment necessitates that patients have contracted an influenza virus and are within the ages of 20 to 75. The study is looking to recruit around 50 individuals."
Is there precedent for this particular therapeutic intervention?
"Currently, 14 different clinical trials are running to investigate this particular treatment. One of these is in its terminal stage - Phase 3 - and the majority are situated at Stanford University, California; though 15 sites in total offer studies for it."
Is the eligibility criterion for this medical trial inclusive of individuals younger than forty?
"In line with the study's requirements, potential participants must be between 20 and 75 years of age."
Does this trial represent a novel approach to treatment?
"Currently, 14 active trials are ongoing across 10 cities and 3 countries for this medication. Initially launched by Pharmacyclics LLC in 2016, the phase 2 clinical trial enrolled 42 participants to meet its drug approval criteria. Subsequently, an additional 143 studies have been conducted over the last 5 years."
Share this study with friends
Copy Link
Messenger